| CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice MT West, CE Smith, A Kaempf, TCL Kohs, R Amirsoltani, J Ribkoff, ... European journal of haematology 106 (5), 634-642, 2021 | 36 | 2021 |
| Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function TJ Zheng, ER Lofurno, AR Melrose, HHS Lakshmanan, J Pang, ... American Journal of Physiology-Cell Physiology 320 (5), C902-C915, 2021 | 30 | 2021 |
| Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus R Silasi, RS Keshari, G Regmi, C Lupu, C Georgescu, JH Simmons, ... Blood, The Journal of the American Society of Hematology 138 (2), 178-189, 2021 | 19 | 2021 |
| Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis TCL Kohs, P Liu, V Raghunathan, R Amirsoltani, M Oakes, OJT McCarty, ... Platelets 33 (4), 570-576, 2022 | 15 | 2022 |
| Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone M Oakes, A Arastu, C Kato, J Somers, HD Holly, BK Elstrott, GW Dy, ... Thrombosis research 207, 96-98, 2021 | 13 | 2021 |
| Development of coagulation factor XII antibodies for inhibiting vascular device-related thrombosis TCL Kohs, CU Lorentz, J Johnson, C Puy, SR Olson, JJ Shatzel, D Gailani, ... Cellular and Molecular Bioengineering 14, 161-175, 2021 | 13 | 2021 |
| Heparin resistance is common in patients undergoing extracorporeal membrane oxygenation but is not associated with worse clinical outcomes V Raghunathan, P Liu, TCL Kohs, R Amirsoltani, M Oakes, OJT McCarty, ... ASAIO Journal 67 (8), 899-906, 2021 | 11 | 2021 |
| Design of a microfluidic bleeding chip to evaluate antithrombotic agents for use in COVID-19 patients HHS Lakshmanan, AA Pore, TCL Kohs, F Yazar, RM Thompson, ... Cellular and molecular bioengineering 13, 331-339, 2020 | 10 | 2020 |
| Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity TJ Zheng, TCL Kohs, PA Mueller, J Pang, SE Reitsma, I Parra-Izquierdo, ... Blood Advances 7 (8), 1366-1378, 2023 | 7 | 2023 |
| The Applications and Challenges of the Development of In Vitro Tumor Microenvironment Chips A Johnson, S Reimer, R Childres, G Cupp, TCL Kohs, OJT McCarty, ... Cellular and Molecular Bioengineering 16 (1), 3-21, 2023 | 7 | 2023 |
| Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo TCL Kohs, SR Olson, J Pang, KR Jordan, TJ Zheng, A Xie, J Hodovan, ... Cellular and Molecular Bioengineering 15 (3), 231-243, 2022 | 6 | 2022 |
| Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice TCL Kohs, ME Fallon, EC Oseas, LD Healy, EI Tucker, D Gailani, ... Metabolic brain disease 38 (7), 2383-2391, 2023 | 5 | 2023 |
| Substrates, cofactors, and cellular targets of coagulation factor XIa AL Lira, TCL Kohs, SA Moellmer, JJ Shatzel, OJT McCarty, C Puy Seminars in thrombosis and hemostasis, 2023 | 4 | 2023 |
| Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia TCL Kohs, HH Vu, KR Jordan, I Parra-Izquierdo, MT Hinds, JJ Shatzel, ... Research and Practice in Thrombosis and Haemostasis 8 (1), 102276, 2024 | 1 | 2024 |
| Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial MA Pfeffer, TCL Kohs, HH Vu, KR Jordan, JSH Wang, CU Lorentz, ... Arteriosclerosis, thrombosis, and vascular biology 44 (1), 290-299, 2024 | 1 | 2024 |
| OC 49.2 Pharmacological Targeting of the Contact Pathway Attenuates Experimental Autoimmune Encephalomyelitis in Mice T Kohs, M Fallon, E Oseas, L Healy, C Lorentz, E Tucker, O McCarty, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | 1 | 2023 |
| Factor XI inhibition for the prevention of catheter-associated thrombosis in cancer patients undergoing central line placement: a phase 2 clinical trial MA Pfeffer, H Vu, TCL Kohs, J Wang, CU Lorentz, EI Tucker, SR Olson, ... Blood 140 (Supplement 1), 1247-1249, 2022 | 1 | 2022 |
| Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis NG Verbout, W Su, P Pham, KR Jordan, TCL Kohs, EI Tucker, ... American Journal of Physiology-Cell Physiology 326 (1), C40-C49, 2024 | | 2024 |
| Factor XI as a therapeutic target in neuroinflammatory disease B Taskin, TCL Kohs, JJ Shatzel, C Puy, OJT McCarty Current opinion in hematology 31 (1), 32-38, 2024 | | 2024 |
| Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry TCL Kohs, BR Weeder, BI Chobrutskiy, T Kartika, KK Moore, OJT McCarty, ... Journal of Thrombosis and Thrombolysis, 1-7, 2023 | | 2023 |
Joseph ShatzelOregon Health & Science UniversityAdresse e-mail validée de ohsu.edu
